Read-Gene S.A. (WSE:RDG)
Poland · Delayed Price · Currency is PLN 6.04
-0.26 (-4.13%)
At close: Oct 10, 2025
Read-Gene Market Cap
Read-Gene has a market cap or net worth of 71.21 million as of October 10, 2025. Its market cap has increased by 2.37% in one year.
Market Cap
71.21M
Enterprise Value
70.62M
Revenue
15.13M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.04
Market Cap Chart
Since February 12, 2009, Read-Gene's market cap has increased from 31.83M to 71.21M, an increase of 123.70%. That is a compound annual growth rate of 4.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 71.21M | 21.77% |
| Dec 30, 2024 | 58.48M | -14.48% |
| Dec 29, 2023 | 68.38M | 124.81% |
| Dec 30, 2022 | 30.42M | -8.19% |
| Dec 29, 2021 | 33.13M | 8.08% |
| Dec 30, 2020 | 30.65M | 293.94% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 6.11B |
| NEUCA | 3.24B |
| Synektik Spólka Akcyjna | 2.19B |
| Voxel | 1.82B |
| Celon Pharma | 1.22B |
| Selvita | 675.48M |
| Centrum Medyczne ENEL-MED | 523.19M |
| Ryvu Therapeutics | 506.61M |